Find Oxycodone Hydrochloride manufacturers, exporters & distributors on PharmaCompass

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 13 USDMF, 11 CEP/COS, 1 JDMF, 1 EU WC, 7 KDMF, 18 NDC API, 15 Listed Suppliers, $ API Reference Price

29 API Suppliers
13 USDMF
11 CEP/COS
1 JDMF
1 EU WC
7 KDMF
18 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

812 FDF Dossiers, 290 FDA Orange Book, 345 Europe, 49 Canada, 52 Australia, 17 South Africa, 59 Listed Dossiers

812 FDF Dossiers
290 FDA Orange Book
345 Europe
49 Canada
52 Australia
17 South Africa
59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 5MG, SOLUTION;ORAL - 100MG/5ML, SOLUTION;ORAL - 5MG/5ML, SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG, TABLET;ORAL - 7.5MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 18MG, CAPSULE, EXTENDED RELEASE;ORAL - 27MG, CAPSULE, EXTENDED RELEASE;ORAL - 36MG, CAPSULE, EXTENDED RELEASE;ORAL - 9MG, TABLET, EXTENDED RELEASE;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 20MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 80MG, TABLET;ORAL - 325MG;5MG

drugProductComposition
CAPSULE;ORAL - 5MG
SOLUTION;ORAL - 100MG/5ML
SOLUTION;ORAL - 5MG/5ML
SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG
TABLET;ORAL - 7.5MG
TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG
CAPSULE, EXTENDED RELEASE;ORAL - 18MG
CAPSULE, EXTENDED RELEASE;ORAL - 27MG
CAPSULE, EXTENDED RELEASE;ORAL - 36MG
CAPSULE, EXTENDED RELEASE;ORAL - 9MG
TABLET, EXTENDED RELEASE;ORAL - 10MG
TABLET, EXTENDED RELEASE;ORAL - 15MG
TABLET, EXTENDED RELEASE;ORAL - 20MG
TABLET, EXTENDED RELEASE;ORAL - 30MG
TABLET, EXTENDED RELEASE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE;ORAL - 80MG
TABLET;ORAL - 325MG;5MG

RELATED EXCIPIENT COMPANIES

15 Evonik, 7 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 18 DKSH, 2 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 16 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 14 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 1 Clariant, 22 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 12 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

relatedExcipients
15 Evonik
7 Rochem International Inc
22 SPI Pharma
2 Seqens
18 DKSH
2 Pharm-RX Chemical
8 Faran Shimi Pharmaceutical
8 Boai NKY Pharmaceuticals Ltd
16 Gangwal Healthcare
7 Nanjing Well Pharmaceutical
3 Pfanstiehl
4 ACG Worldwide
14 Actylis
1 Aeon Procare
2 Alcedo Pharmachem
9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
38 BASF
1 Bioplus Life Sciences
1 Clariant
22 Corel Pharma Chem
7 DFE Pharma
2 Finar
13 Gangwal Chemicals
12 Ideal Cures Pvt Ltd
5 Ingredion Pharma Solutions
39 Kerry
4 Kima Chemical
6 Lonza Capsugel
19 Microlex e.U
2 Nanjing Bold Chemical
2 Nomisma Healthcare
4 Novo Excipients
4 Pharmatrans-Sanaq
9 Pluviaendo
4 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
2 Qualicaps
40 Roquette
14 Seppic
8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
3 Shijiazhuang Huaxu Pharmaceutical
12 Sigachi Industries
3 The Dow Chemical Company
2 Ulanqab Kema New Material
3 Valens Pharmachem
5 Vasa Pharmachem
1 Vertellus
2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

111 Fillers, Diluents & Binders, 84 Coating Systems & Additives, 60 Controlled & Modified Release, 51 Direct Compression, 43 Thickeners and Stabilizers, 43 Taste Masking, 42 Disintegrants & Superdisintegrants, 36 Granulation, 34 Film Formers & Plasticizers, 33 Solubilizers, 28 Parenteral, 26 Lubricants & Glidants, 24 Co-Processed Excipients, 22 Chewable & Orodispersible Aids, 22 Topical, 9 Empty Capsules, 9 API Stability Enhancers, 9 Emulsifying Agents, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 292 NEWS #PharmaBuzz

media
5 DATA COMPILATION #PharmaFlow
292 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 273 Finished Drug Prices, 18 Annual Reports

globalSalesInformation
4 US Medicaid Prescriptions
273 Finished Drug Prices
18 Annual Reports

MARKET PLACE

10 APIs, 9 FDF Dossiers

marketPlace
10 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

225 US Patents, 4 US Exclusivities, 54 Health Canada Patents

patents
225 US Patents
4 US Exclusivities
54 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM , 5 USP , 7 Others

otherSolutions
2 EDQM
5 USP
7 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 1,540

MARKET PLACE

API

FDF

5INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

812

FDF Dossiers

290

FDA Orange Book

345

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

225

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

292

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

598,585,734

Annual Reports (USD Million)

1,486

Finished Drug Prices

429 RELATED EXCIPIENT COMPANIES

707EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 124-90-3, Oxycodone hcl, Oxecta, Oxycontin, Endocodone, Roxicodone

Molecular Formula

C₁₈H₂₂ClNO₄

Molecular Weight

351.8 g/mol

InChI Key

MUZQPDBAOYKNLO-RKXJKUSZSA-N

FDA UNII

C1ENJ2TE6C

A semisynthetic derivative of CODEINE.

1 2D Structure

Oxycodone Hydrochloride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride

2.1.2 InChI

InChI=1S/C18H21NO4.ClH/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;/h3-4,13,16,21H,5-9H2,1-2H3;1H/t13-,16+,17+,18-;/m1./s1

2.1.3 InChI Key

MUZQPDBAOYKNLO-RKXJKUSZSA-N

2.1.4 Canonical SMILES

CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.Cl

2.1.5 Isomeric SMILES

CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O.Cl

2.2 Other Identifiers

2.2.1 UNII

C1ENJ2TE6C

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Dihydrohydroxycodeinone

2. Dihydrone

3. Dinarkon

4. Eucodal

5. Oxiconum

6. Oxycodeinon

7. Oxycodone

8. Oxycone

9. Oxycontin

10. Pancodine

11. Theocodin

2.3.2 Depositor-Supplied Synonyms

1. 124-90-3

2. Oxycodone Hcl

3. Oxecta

4. Oxycontin

5. Endocodone

6. Roxicodone

7. Oxycodone Hydrochloride Cii

8. Chebi:7859

9. 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

10. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride

11. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride

12. Roxicodone (tn)

13. Oxycontin (tn)

14. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride

15. Oxecta (tn)

16. Roxybond

17. Oxycodone Monohydrochloride

18. Schembl30095

19. Oxycodone Hydrochloride (usp)

20. Chembl1200890

21. Dtxsid80924674

22. Oxycodone Hydrochloride [mi]

23. Oxycodone Hydrochloride [usan]

24. Akos024457896

25. Oxycodone Hydrochloride [mart.]

26. Oxycodone Hydrochloride [vandf]

27. Anhydrous Oxycodone Hydrochloride

28. Oxycodone Hydrochloride [who-dd]

29. Oxycodone Hydrochloride, Analytical Standard

30. Oxycodone Hydrochloride [orange Book]

31. Oxycodone Hydrochloride Cii [usp-rs]

32. Oxycodone Hydrochloride [ep Monograph]

33. Tylox Component Oxycodone Hydrochloride

34. C08026

35. Codoxy Component Oxycodone Hydrochloride

36. D00847

37. Oxycet Component Oxycodone Hydrochloride

38. Oxycodone Hydrochloride [usp Monograph]

39. Roxicet Component Oxycodone Hydrochloride

40. Roxilox Component Oxycodone Hydrochloride

41. Troxyca Component Oxycodone Hydrochloride

42. Combunox Component Oxycodone Hydrochloride

43. Oxycodone Hydrochloride Component Of Tylox

44. Percocet Component Oxycodone Hydrochloride

45. Percodan Component Oxycodone Hydrochloride

46. Roxiprin Component Oxycodone Hydrochloride

47. Targiniq Component Oxycodone Hydrochloride

48. Xartemis Component Oxycodone Hydrochloride

49. Oxycodone Hydrochloride Component Of Codoxy

50. Oxycodone Hydrochloride Component Of Oxycet

51. Oxycodone Hydrochloride Component Of Roxicet

52. Oxycodone Hydrochloride Component Of Roxilox

53. Oxycodone Hydrochloride Component Of Troxyca

54. Oxycodone Hydrochloride Component Of Combunox

55. Oxycodone Hydrochloride Component Of Percocet

56. Oxycodone Hydrochloride Component Of Percodan

57. Oxycodone Hydrochloride Component Of Roxiprin

58. Oxycodone Hydrochloride Component Of Targiniq

59. Oxycodone Hydrochloride Component Of Xartemis

60. Percodan-demi Component Oxycodone Hydrochloride

61. Q27107601

62. Oxycodone Hydrochloride Component Of Percodan-demi

63. 14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one Hydrochloride

64. Oxycodone Hydrochloride, European Pharmacopoeia (ep) Reference Standard

65. Oxycodone Hydrochloride, United States Pharmacopeia (usp) Reference Standard

66. (5?)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

67. (5alpha,17s)-14-hydroxy-3-methoxy-17-methyl-6-oxo-4,5-epoxymorphinan-17-ium Chloride

68. 4,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

69. Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, Hydrochloride, (5.alpha.)-

70. Oxycodone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Analytical Standard, For Drug Analysis

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₂ClNO₄
Molecular Weight	351.8 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	1
Exact Mass	351.1237359 g/mol
Monoisotopic Mass	351.1237359 g/mol
Topological Polar Surface Area	59 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	553
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Information

1 of 4
Drug Name	Oxecta
Drug Label	OXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str...
Active Ingredient	Oxycodone hydrochloride
Dosage Form	Tablet
Route	Oral
Strength	7.5mg; 5mg
Market Status	Prescription
Company	Acura Pharms

2 of 4
Drug Name	Oxycodone hydrochloride
Drug Label	DESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration...
Active Ingredient	Oxycodone hydrochloride
Dosage Form	Tablet, extended release; Tablet; Capsule; Solution
Route	oral; Oral
Strength	30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg
Market Status	Tentative Approval; Prescription
Company	Corepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog

3 of 4
Drug Name	Oxecta
Drug Label	OXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str...
Active Ingredient	Oxycodone hydrochloride
Dosage Form	Tablet
Route	Oral
Strength	7.5mg; 5mg
Market Status	Prescription
Company	Acura Pharms

4 of 4
Drug Name	Oxycodone hydrochloride
Drug Label	DESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration...
Active Ingredient	Oxycodone hydrochloride
Dosage Form	Tablet, extended release; Tablet; Capsule; Solution
Route	oral; Oral
Strength	30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg
Market Status	Tentative Approval; Prescription
Company	Corepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Analgesics, Opioid

Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)

Narcotics

Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)

5.2 FDA Pharmacological Classification

5.2.1 Pharmacological Classes

Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

API SUPPLIERS

01

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF

Click Us!

CEP/COS

JDMF EU-WC NDC

KDMF

VMF ROW, CN

AUDIT

02

Parand Darou Pharma

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Parand Darou is a knowledge-based company, focused on the production of Narcotic APIs.

Contact Supplier

Iran

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

03

Faran Shimi Pharmaceutical

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Contact Supplier

Iran

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

Corporate PDF

04

Temad Co

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

MAGHREB PHARMA

Attending

Temad- We think of world-class quality.

Contact Supplier

Iran

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC

NDC KDMF VMF Others AUDIT

05

EUROAPI

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

NextGen Biomed

Attending

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

USDMF CEP/COS

JDMF EU-WC NDC KDMF VMF CN

AUDIT

06

Rusan Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPhI WW Frankfurt

Booth #9.2B82

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

07

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF

CEP/COS

JDMF EU-WC NDC

KDMF

VMF Others AUDIT

08

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF

CEP/COS JDMF EU-WC NDC

KDMF

VMF ROW, CN

AUDIT

09

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF

CEP/COS JDMF EU-WC NDC

KDMF

VMF ROW, CN

AUDIT

10

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Arab Health

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF

CEP/COS

JDMF EU-WC NDC

KDMF

VMF Others AUDIT

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Veranova Lp

U.S.A

IMCAS World Congress

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

OXYCODONE BASE

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 34028

Submission : 2019-10-14

Status : Active

Type : II

02

Veranova Lp

U.S.A

IMCAS World Congress

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

OXYCODONE HCL

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32506

Submission : 2018-03-16

Status : Active

Type : II

03

Veranova Lp

U.S.A

IMCAS World Congress

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

OXYCODONE HYDROCHLORIDE

GDUFA

DMF Review : Complete

Rev. Date : 2014-06-21

Pay. Date : 2014-06-13

DMF Number : 18472

Submission : 2005-06-30

Status : Active

Type : II

04

Noramco Llc

U.S.A

IMCAS World Congress

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

PURIFIED OXYCODONE BASE

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-15

Pay. Date : 2012-11-23

DMF Number : 21353

Submission : 2008-02-21

Status : Active

Type : II

05

Noramco Llc

U.S.A

IMCAS World Congress

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

OXYCODONE HYDROCHLORIDE DRUG SUBSTANCE

GDUFA

DMF Review : Complete

Rev. Date : 2012-12-27

Pay. Date : 2012-11-23

DMF Number : 20975

Submission : 2007-10-26

Status : Active

Type : II

06

Noramco Llc

U.S.A

IMCAS World Congress

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

OXYCODONE HYDROCHLORIDE

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-16

Pay. Date : 2013-04-05

DMF Number : 16399

Submission : 2003-02-03

Status : Active

Type : II

07

Specgx Llc

Ireland

IMCAS World Congress

Not Confirmed

08

Mallinckrodt Chemical Inc

Ireland

IMCAS World Congress

Not Confirmed

09

Penick Corp

Switzerland

IMCAS World Congress

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

01

MACFARLAN SMITH LIMITED Edinburgh G...

U.S.A

IMCAS World Congress

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Oxycodone Hydrochloride

Certificate Number : CEP 2005-036 - Rev 04

Status : Valid

Issue Date : 2024-04-10

Type : Chemical

Substance Number : 1793

02

FRANCOPIA Paris FR

France

NextGen Biomed

Attending

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

Oxycodone Hydrochloride

Certificate Number : CEP 2008-249 - Rev 03

Status : Valid

Issue Date : 2024-03-01

Type : Chemical

Substance Number : 1793

03

NORAMCO, LLC. Wilmington US

U.S.A

IMCAS World Congress

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Oxycodone Hydrochloride

Certificate Number : R1-CEP 2009-058 - Rev 04

Status : Valid

Issue Date : 2022-05-12

Type : Chemical

Substance Number : 1793

04

NORAMCO, LLC. Wilmington US

U.S.A

IMCAS World Congress

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Oxycodone Hydrochloride

Certificate Number : R1-CEP 2011-284 - Rev 02

Status : Valid

Issue Date : 2021-02-24

Type : Chemical

Substance Number : 1793

05

ALKALOIDA CHEMICAL COMPANY ZRT. Tis...

Hungary

IMCAS World Congress

Not Confirmed

06

AREVIPHARMA GMBH Radebeul DE

Germany

IMCAS World Congress

Not Confirmed

07

S.A.L.A.R.S. S.p.A. Como IT

Italy

Switzerland

IMCAS World Congress

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

Veranova

U.S.A

IMCAS World Congress

Not Confirmed

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...

Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships. Operating within two divisions, Generics and Originators, we deliver a differentiated service offering to pharma and biotech customers for every stage in the drug development lifecycle. Macfarlan Smith Limited is trading as Veranova in the United Kingdom.

02

Parand Darou Pharma

Iran

IMCAS World Congress

Not Confirmed

Parand Darou is a knowledge-based company, focused on the production of Narcotic APIs.

Contact Supplier

Iran

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : Parand Daro Pharmaceutical Company is a knowledge-based company that commenced operations in 2015, focusing on the production of narcotic medicinal substances. Parand Daro holds th...

Parand Daro Pharmaceutical Company is a knowledge-based company that commenced operations in 2015, focusing on the production of narcotic medicinal substances. Parand Daro holds the distinction of being the second private sector company in Iran to obtain a license from the Food and Drug Organization to manufacture narcotic products. Leveraging opioid raw materials, Parand Daro has successfully produced potent medicinal substances, including codeine phosphate, noscapine, thebaine, papaverine and oxycodone. Apart from catering to domestic demand, Parand Daro has also expanded its reach by exporting its products to global markets.

03

Faran Shimi Pharmaceutical

Iran

IMCAS World Congress

Not Confirmed

Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Contact Supplier

Iran

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...

Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage forms. For the past three years, the company focused on extracting alkaloid opiates, controlled substances, and narcotics. The APIs are widely used by major pharmaceutical companies nationwide and exported to the Middle East. All production adheres to local GMP standards in an SOP-driven environment with modern systems and utilities, ensuring the highest quality and safety.

Corporate PDF

04

Temad Co

Iran

MAGHREB PHARMA

Attending

Temad- We think of world-class quality.

Contact Supplier

Iran

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...

Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Middle East. Apart from complying with Iranian GMP regulations, Temad has acquired the national & international standards of API manufacturing such as ISO 9001/14001/17025/45001 and OHSAS 18001. It currently manufactures more than 115 pharmaceutical products, including narcotics and non-narcotics, in accordance with GMP and WHO standards and regulations. Temad exports its products to 45 countries worldwide.

05

EUROAPI

France

NextGen Biomed

Attending

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

France

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...

EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Thanks to its excellent R&D skills and six manufacturing facilities across Europe, EUROAPI guarantees API manufacturing of the highest quality to its clients in over 80 countries. Its strong innovation and R&D skills helps it to speed the development of more complex molecule segments through CDMO operations. It also offers experience in supply, regulation and quality. EUROAPI employs 3,350 people and is listed on Euronext.

06

Rusan Pharma

India

CPhI WW Frankfurt

Booth #9.2B82

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Contact Supplier

India

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : Rusan Pharma is a fully integrated global pharmaceutical company specializing in the treatment of addiction & pain management. We manufacture & market a wide range of APIs & formul...

Rusan Pharma is a fully integrated global pharmaceutical company specializing in the treatment of addiction & pain management. We manufacture & market a wide range of APIs & formulations, in the area of controlled substances. Our facilities are GMP-approved by Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia & SAHPRA. We have CEP approval for various APIs such as Buprenorphine, Fentanyl, Naltrexone, Methadone, Bisoprolol & we also manufacture Naloxone, Nalbuphine, Nalmefene, Apomorphine, Efflornithine & Sodium Oxybate. We also develop & manufacture various transdermal patches & long-acting formulations such as depot injections & Implants.

07

Noramco

U.S.A

IMCAS World Congress

Not Confirmed

Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Oxycodone Hydrochloride

About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...

Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and manufacturing, Noramco offers services like supply-chain integration for high-purity controlled substances, efficient routes to APIs, analytical data, stability studies, regulatory help, formulation-friendly particle size grades, extended technical packages, DEA-compliant security and production capacity from kilos to multi-ton supply. Noramco also offers world-class supply security for controlled substances, from Schedule I to Schedule III.

08

Danesh Kimia Pharmed

Iran

IMCAS World Congress

Not Confirmed

09

ITALTECNO

Italy

IMCAS World Congress

Not Confirmed

10

Kimyagaran

Iran

IMCAS World Congress

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714501800,"product":"OXYCODONE HYDROCHLORIDE BASIC DRUG \/ CONTENT 0.495 KG (*FILE NO: XVI\/4\/28\/N\/OXY\/2024)","address":"PLOT NO.58-D,GOVT. INDL.ESTATE,","city":"MUMBAI ,MAHARASHTRA","supplier":"RUSAN PHARMA","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"FSUE MOSCOW ENDOCRINE ","customerCountry":"RUSSIA","quantity":"0.55","actualQuantity":"0.55","unit":"KGS","unitRateFc":"760000","totalValueFC":"5014.7","currency":"INR","unitRateINR":759999.99999999988,"date":"01-May-2024","totalValueINR":"418000","totalValueInUsd":"5014.7","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"9544425","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.58-D,GOVT. INDL.ESTATE,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672079400,"product":"OXYCODONE HYDROCHLORIDE API-EP-0-0-0","address":"A-43, GROUND FLOOR G.T.KARNAL ROAD INDUSTRIAL AREA,","city":"NEW DELHI","supplier":"WOOD & COMPANY FINANCIAL SERVICES","supplierCountry":"SLOVAKIA","foreign_port":"NA","customer":"VENOR PHARMA LIMITED","customerCountry":"INDIA","quantity":"0.96","actualQuantity":"0.96","unit":"KGS","unitRateFc":"1426","totalValueFC":"1490.1","currency":"EUR","unitRateINR":"127912.2","date":"27-Dec-2022","totalValueINR":"122795.71","totalValueInUsd":"1490.1","indian_port":"DELHI AIR","hs_no":"29391100","bill_no":"3922566","productDescription":"API","marketType":"REGULATED MARKET","country":"SLOVAK REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"A-43, GROUND FLOOR G.T.KARNAL ROAD INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672079400,"product":"OXYCODONE HYDROCHLORIDE API-EP-0-0-0","address":"A-43, GROUND FLOOR G.T.KARNAL ROAD INDUSTRIAL AREA,","city":"NEW DELHI","supplier":"WOOD & COMPANY FINANCIAL SERVICES","supplierCountry":"SLOVAKIA","foreign_port":"NA","customer":"VENOR PHARMA LIMITED","customerCountry":"INDIA","quantity":"2.04","actualQuantity":"2.04","unit":"KGS","unitRateFc":"1426","totalValueFC":"3166.5","currency":"EUR","unitRateINR":"127912.2","date":"27-Dec-2022","totalValueINR":"260940.89","totalValueInUsd":"3166.5","indian_port":"DELHI AIR","hs_no":"29391100","bill_no":"3922566","productDescription":"API","marketType":"REGULATED MARKET","country":"SLOVAK REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"A-43, GROUND FLOOR G.T.KARNAL ROAD INDUSTRIAL AREA,"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

01

Faran Shimi Pharmaceutical

Iran

IMCAS World Congress

Not Confirmed

Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Noroxycodone

CAS Number : 57664-96-7

End Use API : Oxycodone Hydrochloride

Corporate PDF

02

Faran Shimi Pharmaceutical

Iran

IMCAS World Congress

Not Confirmed

Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Noroxycodone Hydrochloride

CAS Number : 52446-25-0

End Use API : Oxycodone Hydrochloride

Corporate PDF

03

Faran Shimi Pharmaceutical

Iran

IMCAS World Congress

Not Confirmed

Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

14-Hydroxycodeinone

CAS Number : 508-54-3

End Use API : Oxycodone Hydrochloride

Corporate PDF

04

Temad Co

Iran

MAGHREB PHARMA

Attending

Temad- We think of world-class quality.

Thebaine

CAS Number : 115-37-7

End Use API : Oxycodone Hydrochloride

05

Temad Co

Iran

MAGHREB PHARMA

Attending

Temad- We think of world-class quality.

Codeinone

CAS Number : 467-13-0

End Use API : Oxycodone Hydrochloride

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 5MG

USFDA APPLICATION NUMBER - 200534

DOSAGE - SOLUTION;ORAL - 100MG/5ML

USFDA APPLICATION NUMBER - 200535

DOSAGE - SOLUTION;ORAL - 5MG/5ML

USFDA APPLICATION NUMBER - 200535

DOSAGE - SOLUTION;ORAL - 5MG/5ML **Federal Re...DOSAGE - SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 201194

DOSAGE - TABLET;ORAL - 5MG

USFDA APPLICATION NUMBER - 202080

DOSAGE - TABLET;ORAL - 7.5MG

USFDA APPLICATION NUMBER - 202080

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 325M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 204031

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 13....DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG

USFDA APPLICATION NUMBER - 208090

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 18M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 18MG

USFDA APPLICATION NUMBER - 208090

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 27M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 27MG

USFDA APPLICATION NUMBER - 208090

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 36M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 36MG

USFDA APPLICATION NUMBER - 208090

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 9MG

USFDA APPLICATION NUMBER - 208090

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 10MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 15MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 20MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 30MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 40MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 60MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 80MG

USFDA APPLICATION NUMBER - 22272

DOSAGE - TABLET;ORAL - 325MG;5MG

USFDA APPLICATION NUMBER - 87003

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Coating Systems & Additives

Controlled & Modified Release

Direct Compression

01

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Brand Name : MS90

Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 150-170, Taped Density: 0.80

Ingredient(s) : Starch

02

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Brand Name : Advantose FS95

Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Excipient Details : Advantose® FS95 is spray-dried fructose coprocessed with starch, is a highly compressible pharmaceutical excipient with chewable vitamin applications.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Fructose

03

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Category : Direct Compression, Disintegrants & Superdisintegrants

Brand Name : Solvostar™

Application : Direct Compression, Disintegrants & Superdisintegrants

Excipient Details : Solvostar (Sodium Starch Glycolate) is used as a superdisintegrant and directly compressible excipient in tablets, capsules, suspensions, and pellets.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Solvostar 2% to 8%

Ingredient(s) : Sodium Starch Glycolate

04

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

Brand Name : STARLOSE®

Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

Excipient Details : STARLOSE is used as a diluent, binder, directly compressible (DC), and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : IP/EP/USP-NF/IH

Technical Specs : NA

Ingredient(s) : Lactose Monohydrate

05

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Brand Name : CS90

Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking

Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.

Pharmacopoeia Ref : NA

Technical Specs : PSD D50: 150-175, Tapped Density: 0.85

Ingredient(s) : Calcium Carbonate Excipient

06

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand Name : Pharmaburst 500

Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Pharmaburst® 500 is a directly compressible pharmaceutical excipient used to create orally disintegrating tablets quickly and easily.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

07

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Category : Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand Name : Mannogem® XL Opal

Application : Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Mannogem® XL Opal, directly compressible 160 µm spray-dried mannitol provides superior binding properties and tabletability.

Pharmacopoeia Ref : NA

Technical Specs : 160 µm Powder Mannitol

Ingredient(s) : Mannitol

08

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Brand Name : Advantol 300

Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking

Excipient Details : Advantol® 300 is a DC pharmaceutical excipient used to create soft chewable or soft melt oral dosage forms & enables rapid product development.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

09

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Category : Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Lubricants & Glidants

Brand Name : ProBlend®

Application : Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Lubricants & Glidants

Excipient Details : ProBlend (Microcrystalline Cellulose) is used as a filler, binder, glidant, DC & co-processed excipient in tablets, capsules, and MUPS formulations.

Pharmacopoeia Ref : USP-NF

Technical Specs : NA

Ingredient(s) : Microcrystalline Cellulose

10

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Orodispersible Tablet, Tablet

Grade : Oral

Category : Chewable & Orodispersible Aids, Direct Compression

Brand Name : DC CoDried

Application : Chewable & Orodispersible Aids, Direct Compression

Excipient Details : DC CoDried Powders are pre-formulated, DC aluminum hydroxide & magnesium hydroxide products used in the manufacturing of chewable antacids tablets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Aluminum Hydroxide Excipient

Only 10 entries up to this point, click to access all

Thickeners and Stabilizers

01

Pfanstiehl

U.S.A

IMCAS World Congress

Not Confirmed

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Dosage Form : Injectable / Parenteral

Grade : Parenteral

Category : Parenteral, Thickeners and Stabilizers

Brand Name : Sucrose

Application : Parenteral, Thickeners and Stabilizers

Excipient Details : Sucrose is used to stabilize proteins, lipids, carbohydrates, ADCs & vaccines. It is also used as a cryopreservative in cell-based bioprocesses.

Pharmacopoeia Ref : USDMF, NF, EP, JP, ChP

Technical Specs : N/A

Ingredient(s) : Sucrose

02

Rochem International Inc

U.S.A

CPhI WW Frankfurt

Booth #12.0F117

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Dosage Form : Cream / Lotion / Ointment, Suspension

Grade : Topical

Category : API Stability Enhancers, Thickeners and Stabilizers

Brand Name : Xanthan Gum

Application : API Stability Enhancers, Thickeners and Stabilizers

Excipient Details : Xanthan gum, a polysaccharide widely used in many industries as a food additive, thickening agent and stabilizer in topical formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Xanthan Gum

03

Rochem International Inc

U.S.A

CPhI WW Frankfurt

Booth #12.0F117

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Dosage Form : Capsule, Granule / Pellet, Suspension, Syrup, Tablet

Grade : Oral

Category : Coating Systems & Additives, Fillers, Diluents & Binders, Taste Masking, Thickeners and Stabilizers

Brand Name : Maltitol

Application : Coating Systems & Additives, Fillers, Diluents & Binders, Taste Masking, Thickeners and Stabilizers

Excipient Details : Maltitol is widely used as a coating agent, diluent, sweetener and bulking agent in various dosage forms such as tablets, capsules, granules & syrups.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Maltitol Excipient

04

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Gel, Suspension

Grade : Oral

Category : Thickeners and Stabilizers

Brand Name : VAC Gel

Application : Thickeners and Stabilizers

Excipient Details : SPI® VAC Gels are based on highly engineered pseudo-boehmite and are used as vaccine adjuvants.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Aluminum Hydroxide Excipient

05

DKSH

Switzerland

CPhI WW Frankfurt

Booth #8.0P66

DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Dosage Form : Capsule, Granule / Pellet, Tablet, Injectable / Parenteral

Grade : Parenteral, Oral

Category : Fillers, Diluents & Binders, Thickeners and Stabilizers

Brand Name : GELATIN BOVINE 140B 6M

Application : Fillers, Diluents & Binders, Thickeners and Stabilizers

Excipient Details : Gelatin bovine 140B 6M is used as a stabilizer in parenteral drug products and as a binder and filler in capsules, tablets, granules, and pellets.

Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

Technical Specs : N/A

Ingredient(s) : Gelatin Excipient

06

Pharm-RX Chemical

U.S.A

Natural Products Expo

Booth #4451

Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.

Dosage Form : Cream / Lotion / Ointment, Capsule, Gel, Tablet

Grade : Oral, Topical

Category : API Stability Enhancers, Thickeners and Stabilizers

Brand Name : Xanthan Gum

Application : API Stability Enhancers, Thickeners and Stabilizers

Excipient Details : Xanthan Gum is widely used in oral dosage forms as a suspending and thickening agent. It is also used in topical formulations as stabilizer.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Xanthan Gum

07

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Thickeners and Stabilizers

Brand Name : DiCOM-DC® SP204

Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Thickeners and Stabilizers

Excipient Details : DiCOM-DC SP204 is used as a stabilizer, filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Ingredient(s) : Corn Starch, Pregelatinized

08

Nanjing Well Pharmaceutical

China

IMCAS World Congress

Not Confirmed

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet

Grade : Parenteral, Oral, Topical

Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

Brand Name : Polysorbate 80

Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

Ingredient(s) : Polysorbate 80

09

Pfanstiehl

U.S.A

IMCAS World Congress

Not Confirmed

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Dosage Form : Injectable / Parenteral, Tablet

Grade : Parenteral, Oral

Category : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers

Brand Name : D-Mannitol

Application : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers

Excipient Details : D-mannitol protects proteins from denaturation & degradation. It is also used as a stabilizer in liquid formulations & as a bulking agent in tablets.

Pharmacopoeia Ref : USP, NF, EP, JP, ChP

Technical Specs : N/A

Ingredient(s) : Mannitol

10

DKSH

Switzerland

CPhI WW Frankfurt

Booth #8.0P66

DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Dosage Form : Capsule, Granule / Pellet, Tablet, Injectable / Parenteral

Grade : Parenteral, Oral

Category : Fillers, Diluents & Binders, Thickeners and Stabilizers

Brand Name : GELITA

Application : Fillers, Diluents & Binders, Thickeners and Stabilizers

Excipient Details : Gelita RXL R² 115B BB TB Ph is used as a stabilizer in parenteral formulations and as a filler and binder in tablets, capsules, granules, and pellets.

Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

Technical Specs : N/A

Ingredient(s) : Gelatin Excipient

Only 10 entries up to this point, click to access all

Taste Masking

Disintegrants & Superdisintegrants

01

Evonik

Germany

ESF Europe

Attending

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Granule / Pellet, Orodispersible Tablet, Powder, Tablet

Grade : Oral

Category : Coating Systems & Additives, Controlled & Modified Release, Disintegrants & Superdisintegrants, Film Formers & Plasticizers, Taste Masking

Brand Name : EUDRAGIT® E 100

Application : Coating Systems & Additives, Controlled & Modified Release, Disintegrants & Superdisintegrants, Film Formers & Plasticizers, Taste Masking

Excipient Details : EUDRAGIT® E 100 (granules) is an immediate-release polymer used as a taste masking, coating agent & film former in tablets, capsules, powders & ODTs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Amino Methacrylate Copolymer

02

Faran Shimi Pharmaceutical

Iran

IMCAS World Congress

Not Confirmed

Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Dosage Form : Tablet

Grade : Oral

Category : Disintegrants & Superdisintegrants

Brand Name : Croscarmellose Sodium

Application : Disintegrants & Superdisintegrants

Excipient Details : Croscarmellose sodium is used as a super disintegrant in various oral solid dosage forms, such as tablets and ODTs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Croscarmellose Sodium

03

Boai NKY Pharmaceuticals Ltd

China

IMCAS World Congress

Not Confirmed

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Dosage Form : Tablet

Grade : Oral (Pharma Grade)

Category : Disintegrants & Superdisintegrants

Brand Name : PolyKoVidone Ultra XL

Application : Disintegrants & Superdisintegrants

Excipient Details : PolyKoVidone Ultra XL is used as a superdisintegrant and solid dispersant aid in solid dosage forms such as tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Ingredient(s) : Crospovidone

04

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Tablet

Grade : Oral

Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders

Brand Name : Innogel 9000/9500

Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders

Excipient Details : Innogel 9000/9500 (Pregelatinized Starch) is used as filler, binder, disintegrant, and superdisintegrant in tablets and capsules.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : NA

Ingredient(s) : Corn Starch, Pregelatinized

05

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Category : Direct Compression, Disintegrants & Superdisintegrants

Brand Name : Solvostar™

Application : Direct Compression, Disintegrants & Superdisintegrants

Excipient Details : Solvostar (Sodium Starch Glycolate) is used as a superdisintegrant and directly compressible excipient in tablets, capsules, suspensions, and pellets.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Solvostar 2% to 8%

Ingredient(s) : Sodium Starch Glycolate

06

Pluviaendo

Turkey

IMCAS World Congress

Not Confirmed

07

Boai NKY Pharmaceuticals Ltd

China

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Dosage Form : Tablet

Grade : Oral (Pharma Grade)

Category : Disintegrants & Superdisintegrants

Brand Name : PolyKoVidone Ultra XL-10

Application : Disintegrants & Superdisintegrants

Excipient Details : PolyKoVidone Ultra XL-10 is used as a superdisintegrant and solid dispersant aid in solid dosage forms such as tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Ingredient(s) : Crospovidone

08

Boai NKY Pharmaceuticals Ltd

China

IMCAS World Congress

Not Confirmed

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Dosage Form : Tablet

Grade : Oral (Pharma Grade)

Category : Disintegrants & Superdisintegrants

Brand Name : PolyKoVidone XL

Application : Disintegrants & Superdisintegrants

Excipient Details : PolyKoVidone XL is used as a superdisintegrant and solid dispersant aid in solid dosage forms such as tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Ingredient(s) : Crospovidone

09

Boai NKY Pharmaceuticals Ltd

China

IMCAS World Congress

Not Confirmed

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Dosage Form : Tablet

Grade : Oral (Pharma Grade)

Category : Disintegrants & Superdisintegrants

Brand Name : PolyKoVidone XL-10

Application : Disintegrants & Superdisintegrants

Excipient Details : PolyKoVidone XL-10 is used as a superdisintegrant and solid dispersant aid in solid dosage forms such as tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Ingredient(s) : Crospovidone

10

Gangwal Healthcare

India

CPhI South East Asia

Attending

Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Category : Disintegrants & Superdisintegrants

Brand Name : Sallyso™

Application : Disintegrants & Superdisintegrants

Excipient Details : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Sallyso 0.5 to 3.0%

Ingredient(s) : Croscarmellose Sodium

Only 10 entries up to this point, click to access all

Granulation

Film Formers & Plasticizers

Solubilizers

Parenteral

Lubricants & Glidants

Co-Processed Excipients

Chewable & Orodispersible Aids

Topical

Empty Capsules

API Stability Enhancers

01

Rochem International Inc

U.S.A

CPhI WW Frankfurt

Booth #12.0F117

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Dosage Form : Cream / Lotion / Ointment, Suspension

Grade : Topical

Category : API Stability Enhancers, Thickeners and Stabilizers

Brand Name : Xanthan Gum

Application : API Stability Enhancers, Thickeners and Stabilizers

Excipient Details : Xanthan gum, a polysaccharide widely used in many industries as a food additive, thickening agent and stabilizer in topical formulations.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Xanthan Gum

02

SPI Pharma

U.S.A

IMCAS World Congress

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet, Orodispersible Tablet

Grade : Oral

Category : API Stability Enhancers, Chewable & Orodispersible Aids, Fillers, Diluents & Binders

Brand Name : Mannogem XL Mannitol

Application : API Stability Enhancers, Chewable & Orodispersible Aids, Fillers, Diluents & Binders

Excipient Details : Mannogem® XL is a DC spray-dried mannitol used to enhance mannitol formulation tabletability & provide superior binding & quick disintegration.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Mannitol

03

Pharm-RX Chemical

U.S.A

Natural Products Expo

Booth #4451

Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.

Dosage Form : Cream / Lotion / Ointment, Capsule, Gel, Tablet

Grade : Oral, Topical

Category : API Stability Enhancers, Thickeners and Stabilizers

Brand Name : Xanthan Gum

Application : API Stability Enhancers, Thickeners and Stabilizers

Excipient Details : Xanthan Gum is widely used in oral dosage forms as a suspending and thickening agent. It is also used in topical formulations as stabilizer.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Xanthan Gum

Excipients Web Link

U.S.A

IMCAS World Congress

Not Confirmed

Only 10 entries up to this point, click to access all

Emulsifying Agents

Rheology Modifiers

Coloring Agents

Vegetarian Capsules

Surfactant & Foaming Agents

Soft Gelatin

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-Myers Squibb acquiring New Jersey-based cancer drug company Celgene in a US$ 74 billion deal announced on January 3, 2019. After factoring in debt, the deal value ballooned to about US$ 95 billion, which according to data compiled by Refinitiv, made it the largest healthcare deal on record. In the summer, AbbVie Inc, which sells the world’s best-selling drug Humira, announced its acquisition of Allergan Plc, known for Botox and other cosmetic treatments, for US$ 63 billion. While the companies are still awaiting regulatory approval for their deal, with US$ 49 billion in combined 2019 revenues, the merged entity would rank amongst the biggest in the industry. View Our Interactive Dashboard on Top drugs by sales in 2019 (Free Excel Available) The big five by pharmaceutical sales — Pfizer, Roche, J&J, Novartis and Merck Pfizer continued to lead companies by pharmaceutical sales by reporting annual 2019 revenues of US$ 51.8 billion, a decrease of US$ 1.9 billion, or 4 percent, compared to 2018. The decline was primarily attributed to the loss of exclusivity of Lyrica in 2019, which witnessed its sales drop from US$ 5 billion in 2018 to US$ 3.3 billion in 2019. In 2018, Pfizer’s then incoming CEO Albert Bourla had mentioned that the company did not see the need for any large-scale M&A activity as Pfizer had “the best pipeline” in its history, which needed the company to focus on deploying its capital to keep its pipeline flowing and execute on its drug launches. Bourla stayed true to his word and barring the acquisition of Array Biopharma for US$ 11.4 billion and a spin-off to merge Upjohn, Pfizer’s off-patent branded and generic established medicines business with Mylan, there weren’t any other big ticket deals which were announced. The Upjohn-Mylan merged entity will be called Viatris and is expected to have 2020 revenues between US$ 19 and US$ 20 billion and could outpace Teva to become the largest generic company in the world, in term of revenues. Novartis, which had followed Pfizer with the second largest revenues in the pharmaceutical industry in 2018, reported its first full year earnings after spinning off its Alcon eye care devices business division that had US$ 7.15 billion in 2018 sales. In 2019, Novartis slipped two spots in the ranking after reporting total sales of US$ 47.4 billion and its CEO Vas Narasimhan continued his deal-making spree by buying New Jersey-headquartered The Medicines Company (MedCo) for US$ 9.7 billion to acquire a late-stage cholesterol-lowering therapy named inclisiran. As Takeda Pharmaceutical Co was busy in 2019 on working to reduce its debt burden incurred due to its US$ 62 billion purchase of Shire Plc, which was announced in 2018, Novartis also purchased the eye-disease medicine, Xiidra, from the Japanese drugmaker for US$ 5.3 billion. Novartis’ management also spent a considerable part of 2019 dealing with data-integrity concerns which emerged from its 2018 buyout of AveXis, the gene-therapy maker Novartis had acquired for US$ 8.7 billion. The deal gave Novartis rights to Zolgensma, a novel treatment intended for children less than two years of age with the most severe form of spinal muscular atrophy (SMA). Priced at US$ 2.1 million, Zolgensma is currently the world’s most expensive drug. However, in a shocking announcement, a month after approving the drug, the US Food and Drug Administration (FDA) issued a press release on data accuracy issues as the agency was informed by AveXis that its personnel had manipulated data which the FDA used to evaluate product comparability and nonclinical (animal) pharmacology as part of the biologics license application (BLA), which was submitted and reviewed by the FDA. With US$ 50.0 billion (CHF 48.5 billion) in annual pharmaceutical sales, Swiss drugmaker Roche came in at number two position in 2019 as its sales grew 11 percent driven by its multiple sclerosis medicine Ocrevus, haemophilia drug Hemlibra and cancer medicines Tecentriq and Perjeta. Roche’s newly introduced medicines generated US$ 5.53 billion (CHF 5.4 billion) in growth, helping offset the impact of the competition from biosimilars for its three best-selling drugs MabThera/Rituxan, Herceptin and Avastin. In late 2019, after months of increased antitrust scrutiny, Roche completed its US$ 5.1 billion acquisition of Spark Therapeutics to strengthen its presence in gene therapy. Last year, J&J reported almost flat worldwide sales of US$ 82.1 billion. J&J’s pharmaceutical division generated US$ 42.20 billion and its medical devices and consumer health divisions brought in US$ 25.96 billion and US$ 13.89 billion respectively. Since J&J’s consumer health division sells analgesics, digestive health along with beauty and oral care products, the US$ 5.43 billion in consumer health sales from over-the-counter drugs and women’s health products was only used in our assessment of J&J’s total pharmaceutical revenues. With combined pharmaceutical sales of US$ 47.63 billion, J&J made it to number three on our list. While the sales of products like Stelara, Darzalex, Imbruvica, Invega Sustenna drove J&J’s pharmaceutical business to grow by 4 percent over 2018, the firm had to contend with generic competition against key revenue contributors Remicade and Zytiga. US-headquartered Merck, which is known as MSD (short for Merck Sharp & Dohme) outside the United States and Canada, is set to significantly move up the rankings next year fueled by its cancer drug Keytruda, which witnessed a 55 percent increase in sales to US$ 11.1 billion. Merck reported total revenues of US$ 41.75 billion and also announced it will spin off its women’s health drugs, biosimilar drugs and older products to create a new pharmaceutical company with US$ 6.5 billion in annual revenues. The firm had anticipated 2020 sales between US$ 48.8 billion and US$ 50.3 billion however this week it announced that the coronavirus pandemic will reduce 2020 sales by more than $2 billion. View Our Interactive Dashboard on Top drugs by sales in 2019 (Free Excel Available) Humira holds on to remain world’s best-selling drug AbbVie’s acquisition of Allergan comes as the firm faces the expiration of patent protection for Humira, which brought in a staggering US$ 19.2 billion in sales last year for the company. AbbVie has failed to successfully acquire or develop a major new product to replace the sales generated by its flagship drug. In 2019, Humira’s US revenues increased 8.6 percent to US$ 14.86 billion while internationally, due to biosimilar competition, the sales dropped 31.1 percent to US$ 4.30 billion. Bristol Myers Squibb’s Eliquis, which is also marketed by Pfizer, maintained its number two position and posted total sales of US$ 12.1 billion, a 23 percent increase over 2018. While Bristol Myers Squibb’s immunotherapy treatment Opdivo, sold in partnership with Ono in Japan, saw sales increase from US$ 7.57 billion to US$ 8.0 billion, the growth paled in comparison to the US$ 3.9 billion revenue increase of Opdivo’s key immunotherapy competitor Merck’s Keytruda. Keytruda took the number three spot in drug sales that previously belonged to Celgene’s Revlimid, which witnessed a sales decline from US$ 9.69 billion to US$ 9.4 billion. Cancer treatment Imbruvica, which is marketed by J&J and AbbVie, witnessed a 30 percent increase in sales. With US$ 8.1 billion in 2019 revenues, it took the number five position. View Our Interactive Dashboard on Top drugs by sales in 2019 (Free Excel Available) Vaccines – Covid-19 turns competitors into partners This year has been dominated by the single biggest health emergency in years — the novel coronavirus (Covid-19) pandemic. As drugs continue to fail to meet expectations, vaccine development has received a lot of attention. GSK reported the highest vaccine sales of all drugmakers with total sales of US$ 8.4 billion (GBP 7.16 billion), a significant portion of its total sales of US$ 41.8 billion (GBP 33.754 billion). US-based Merck’s vaccine division also reported a significant increase in sales to US$ 8.0 billion and in 2019 received FDA and EU approval to market its Ebola vaccine Ervebo. This is the first FDA-authorized vaccine against the deadly virus which causes hemorrhagic fever and spreads from person to person through direct contact with body fluids. Pfizer and Sanofi also reported an increase in their vaccine sales to US$ 6.4 billion and US$ 6.2 billion respectively and the Covid-19 pandemic has recently pushed drugmakers to move faster than ever before and has also converted competitors into partners. In a rare move, drug behemoths — Sanofi and GlaxoSmithKline (GSK) —joined hands to develop a vaccine for the novel coronavirus. The two companies plan to start human trials in the second half of this year, and if things go right, they will file for potential approvals by the second half of 2021. View Our Interactive Dashboard on Top drugs by sales in 2019 (Free Excel Available) Our view Covid-19 has brought the world economy to a grinding halt and shifted the global attention to the pharmaceutical industry’s capability to deliver solutions to address this pandemic. Our compilation shows that vaccines and drugs for infectious diseases currently form a tiny fraction of the total sales of pharmaceutical companies and few drugs against infectious diseases rank high on the sales list. This could well explain the limited range of options currently available to fight Covid-19. With the pandemic currently infecting over 3 million people spread across more than 200 countries, we can safely conclude that the scenario in 2020 will change substantially. And so should our compilation of top drugs for the year. View Our Interactive Dashboard on Top drugs by sales in 2019 (Free Excel Available)

Impressions: 55519

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

01

Brand Name : Oxaydo

Country

IMCAS World Congress

Not Confirmed

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

01

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

02

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : CAPSULE;ORAL

Dosage Strength : 5MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

03

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : SOLUTION;ORAL

Dosage Strength : 100MG/5ML

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

04

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

05

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

06

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

07

Brand Name : OXYCODONE HYDROCHLORIDE

India

BioAsia

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

RX/OTC/DISCN : DISCN

DR REDDYS LABS SA

Oxycodone Hydrochloride

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Price Per Pack :

Published in :

Country : USA

RX/OTC/DISCN : DISCN

Product Web Link

08

Brand Name : Oxynorm

Germany

IMCAS World Congress

Not Confirmed

09

Brand Name : Oxynorm

Germany

IMCAS World Congress

Not Confirmed

10

Brand Name : Oxycodone Vita Balance

Country

IMCAS World Congress

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Health Canada Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USP

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Oxycodone Hydrochloride Manufacturers

A Oxycodone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxycodone Hydrochloride, including repackagers and relabelers. The FDA regulates Oxycodone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxycodone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Oxycodone Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Oxycodone Hydrochloride Suppliers

A Oxycodone Hydrochloride supplier is an individual or a company that provides Oxycodone Hydrochloride active pharmaceutical ingredient (API) or Oxycodone Hydrochloride finished formulations upon request. The Oxycodone Hydrochloride suppliers may include Oxycodone Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Oxycodone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Oxycodone Hydrochloride USDMF

A Oxycodone Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxycodone Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Oxycodone Hydrochloride DMFs exist exist since differing nations have different regulations, such as Oxycodone Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Oxycodone Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Oxycodone Hydrochloride USDMF includes data on Oxycodone Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxycodone Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Oxycodone Hydrochloride suppliers with USDMF on PharmaCompass.

Oxycodone Hydrochloride JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Oxycodone Hydrochloride Drug Master File in Japan (Oxycodone Hydrochloride JDMF) empowers Oxycodone Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Oxycodone Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Oxycodone Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Oxycodone Hydrochloride suppliers with JDMF on PharmaCompass.

Oxycodone Hydrochloride KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Oxycodone Hydrochloride Drug Master File in Korea (Oxycodone Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxycodone Hydrochloride. The MFDS reviews the Oxycodone Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Oxycodone Hydrochloride KDMF to evaluate the safety and efficacy of the drug.

After submitting a Oxycodone Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxycodone Hydrochloride API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Oxycodone Hydrochloride suppliers with KDMF on PharmaCompass.

Oxycodone Hydrochloride CEP

A Oxycodone Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Oxycodone Hydrochloride Certificate of Suitability (COS). The purpose of a Oxycodone Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxycodone Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxycodone Hydrochloride to their clients by showing that a Oxycodone Hydrochloride CEP has been issued for it. The manufacturer submits a Oxycodone Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxycodone Hydrochloride CEP holder for the record. Additionally, the data presented in the Oxycodone Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxycodone Hydrochloride DMF.

A Oxycodone Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxycodone Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Oxycodone Hydrochloride suppliers with CEP (COS) on PharmaCompass.

Oxycodone Hydrochloride WC

A Oxycodone Hydrochloride written confirmation (Oxycodone Hydrochloride WC) is an official document issued by a regulatory agency to a Oxycodone Hydrochloride manufacturer, verifying that the manufacturing facility of a Oxycodone Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxycodone Hydrochloride APIs or Oxycodone Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxycodone Hydrochloride WC (written confirmation) as part of the regulatory process.

click here to find a list of Oxycodone Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.

Oxycodone Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxycodone Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Oxycodone Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Oxycodone Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Oxycodone Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxycodone Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Oxycodone Hydrochloride suppliers with NDC on PharmaCompass.

Oxycodone Hydrochloride GMP

Oxycodone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Oxycodone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxycodone Hydrochloride GMP manufacturer or Oxycodone Hydrochloride GMP API supplier for your needs.

Oxycodone Hydrochloride CoA

A Oxycodone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Oxycodone Hydrochloride's compliance with Oxycodone Hydrochloride specifications and serves as a tool for batch-level quality control.

Oxycodone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Oxycodone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Oxycodone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxycodone Hydrochloride EP), Oxycodone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxycodone Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

Market Place

Home

Post Enquiry

Market Place

Find Oxycodone Hydrochloride manufacturers, exporters & distributors on PharmaCompass

Oxycodone Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers

13 USDMF

11 CEP/COS

1 JDMF

1 EU WC

7 KDMF

18 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

812 FDF Dossiers

290 FDA Orange Book

345 Europe

49 Canada

52 Australia

17 South Africa

59 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 5MG

SOLUTION;ORAL - 100MG/5ML

SOLUTION;ORAL - 5MG/5ML

SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG

TABLET;ORAL - 7.5MG

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG

CAPSULE, EXTENDED RELEASE;ORAL - 18MG

CAPSULE, EXTENDED RELEASE;ORAL - 27MG

CAPSULE, EXTENDED RELEASE;ORAL - 36MG

CAPSULE, EXTENDED RELEASE;ORAL - 9MG

TABLET, EXTENDED RELEASE;ORAL - 10MG

TABLET, EXTENDED RELEASE;ORAL - 15MG

TABLET, EXTENDED RELEASE;ORAL - 20MG

TABLET, EXTENDED RELEASE;ORAL - 30MG

TABLET, EXTENDED RELEASE;ORAL - 40MG

TABLET, EXTENDED RELEASE;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 80MG

TABLET;ORAL - 325MG;5MG

RELATED EXCIPIENT COMPANIES

15 Evonik

7 Rochem International Inc

22 SPI Pharma

2 Seqens

18 DKSH

2 Pharm-RX Chemical

8 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

16 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Pfanstiehl

4 ACG Worldwide

14 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

38 BASF

1 Bioplus Life Sciences

1 Clariant

22 Corel Pharma Chem

7 DFE Pharma

2 Finar

13 Gangwal Chemicals

12 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

4 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

2 Nanjing Bold Chemical

SOLUTION;ORAL - 5MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons